A5039303344- Organ Transplantation Techniques and Outcomes
- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Renal Transplantation Outcomes and Treatments
- Gastric Cancer Management and Outcomes
- Genital Health and Disease
- Tumors and Oncological Cases
- Clinical Nutrition and Gastroenterology
- Cancer Diagnosis and Treatment
- Gallbladder and Bile Duct Disorders
- Peptidase Inhibition and Analysis
- Biliary and Gastrointestinal Fistulas
- Pharmacogenetics and Drug Metabolism
- Silymarin and Mushroom Poisoning
- Prostate Cancer Treatment and Research
- Congenital Anomalies and Fetal Surgery
- Diversity and Career in Medicine
- Hospital Admissions and Outcomes
- Organ Donation and Transplantation
- Esophageal Cancer Research and Treatment
- Cardiac, Anesthesia and Surgical Outcomes
- Cancer Mechanisms and Therapy
- Medical Imaging and Pathology Studies
Medical University of Warsaw
2015-2025
Central Clinical Hospital
2015
The magnitude of pre-transplant a-fetoprotein (AFP) changes has been advocated to be a superior predictor hepatocellular cancer (HCC) recurrence following liver transplantation. aim this study was compare AFP dynamics and last as risk factors for post-transplant HCC recurrence.Data 146 patients after transplantation were analyzed retrospectively.While significant microvascular invasion (p=0.006) poor tumor differentiation (p=0.020), slope associated only with (p=0.029). Notably, (p<0.001),...
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Patkowski W, Krasnodębski M, Grąt Masior Ł, Krawczyk M. Surgical treatment of hepatic Echinococcus granulosus. Gastroenterology Review/Przegląd Gastroenterologiczny. 2017;12(3):199-202. doi:10.5114/pg.2017.70473. APA Patkowski, W., Krasnodębski, M., Grąt, Masior, Ł., & Krawczyk, (2017). Gastroenterologiczny, 12(3), 199-202. https://doi.org/10.5114/pg.2017.70473 Chicago Waldemar, Maciej Michał Łukasz and Marek...
Combination of the University California, San Francisco (UCSF) and up-to-7 criteria with alpha-fetoprotein (AFP) cutoff 100 ng/ml was proposed as Warsaw expansion Milan in selection hepatocellular cancer (HCC) patients for liver transplantation. The purpose this retrospective study to validate proposal.A total 240 HCC after transplantation were included. Recurrence-free survival overall at 5 years set primary secondary outcome measures, respectively.The increased transplant eligibility rate...
BackgroundProlonged cold ischemic time (CIT) and increased donor age are well-known factors negatively influencing outcomes after liver transplantation (LT).The aim of this study was to evaluate whether the magnitude their negative effects is related recipient model for end-stage disease (MELD) score.This retrospective based on a cohort 1402 LTs, divided into those performed in low-MELD (<10), moderate-MELD (10–20), high-MELD (>20) recipients.While neither (p = 0.775) nor CIT 0.561)...
Background: The need for safe and efficient dissemination of minimally invasive approach in liver surgery is among the current challenges hepatobiliary surgeons. After stage innovators pioneers, following countries should adopt a laparoscopic approach. aim this study was to assess national experience trend implementing resection (LLR) Poland. Materials Methods: A registry LLR performed Poland established June 2020. All cases before were included retrospectively, followed by prospectively...
BACKGROUND The aim of this study was to assess risk factors for postoperative mortality after liver transplantation among patients with Model End-Stage Liver Disease (MELD) scores ≥35, special focus on the MELD scores. MATERIAL AND METHODS Data from 68 primary transplantations in ≥35 1376 performed Department General, Transplant, and Surgery (Medical University Warsaw) between January 2002 October 2014 were analyzed retrospectively. Postoperative (90-day) set as outcome measure. RESULTS...
Abstract Microvascular invasion (MVI) is well known to negatively influence outcomes following surgical treatment of hepatocellular cancer (HCC) patients. The aim this study was evaluate the rationale for prediction MVI before liver transplantation (LT). Data 200 HCC patients after LT were subject retrospective analysis. present in 57 (28.5%). Tumor number (p = 0.001) and size 0.009), alpha-fetoprotein 0.049) independent predictors used create a model, defined as: 0.293x(tumor number) +...
Transarterial chemoembolization (TACE) is used as a bridging treatment in liver transplant candidates with hepatocellular carcinoma (HCC). Alpha-fetoprotein (AFP) the main tumor marker for HCC surveillance. The aim of this study was to assess potential using AFP change after first TACE prediction complete necrosis. comprised 101 patients who underwent transplantation (LT) period between January 2011 and December 2020. ΔAFP defined difference value before either second or LT. receiver...
Abstract Liver transplantation is a well-established treatment of patients with end-stage liver disease and selected tumors. Remarkable progress has been made over the last years concerning nearly all its aspects. was to evaluate evolution long-term outcomes after transplantations performed in Department General, Transplant Surgery (Medical University Warsaw). Data 1500 between 1989 2014 were retrospectively analyzed. Transplantations divided into 3 groups: group 1 including first 500...
Perioperative use of probiotics serves as efficient prophylaxis against postoperative infections after liver transplantation, yet data on long-term effects pre-transplant probiotic intake is lacking. The aim this study was to assess the administration results transplantation. This secondary analysis a randomized trial. Patients were receive either 4-strain or placebo before Five year graft survival set primary end-point. Secondary end-points comprised serum bilirubin and C-reactive protein...
Abstract Intraabdominal hemorrhage remains one of the most frequent surgical complications after liver transplantation. The aim study was to evaluate risk factors for intraabdominal bleeding requiring reoperation and assess relevance reoperations with respect short- long-term outcomes following Material methods. Data 603 transplantations performed in Department General, Transplant Liver Surgery period between January 2011 September 2014 were analyzed retrospectively. Study end-points...
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Krasnodębski M, Grąt Hołówko W, et al. Results of liver transplantation in patients with acute failure due to Amanita phalloides and paracetamol (acetaminophen) intoxication. Gastroenterology Review/Przegląd Gastroenterologiczny. 2016;11(2):90-95. doi:10.5114/pg.2015.52031. APA Krasnodębski, M., Grąt, Hołówko, W., Masior, Ł., Wronka, K., & K. (2016). Gastroenterologiczny, 11(2), 90-95....
Cryptogenic cirrhosis (CC) is an indication for liver transplantation in 5-9% of recipients. Diagnosis made when other diagnostic possibilities have been ruled out. The aim this study was to present long-term outcomes CC.There 1367 transplantations performed during the years 1994-2013 Department General, Transplant and Liver Surgery at Medical University Warsaw. This retrospective comprised 55 patients after CC (4.0%). Perioperative mortality (30 days) patient graft 1-, 5-, 10-year survival...
Liver transplantation (LT) is a well-established method applied for the treatment of various liver diseases, including primary and secondary malignancies, as well acute failure triggered by different mechanisms. In turn, (PHLF) most severe complication observed after resection (LR). PHLF an extremely rare indication LT. The aim present study was to assess results LT in patients with PHLF.
BACKGROUND The impact of packed red blood cells (PRBCs) and fresh frozen plasma (FFP) transfusions in patients with hepatocellular cancer (HCC) undergoing liver transplantation has rarely been evaluated. aim the current study was to assess intraoperative on posttransplant outcomes. MATERIAL AND METHODS This retrospective cohort based 229 HCC transplant recipients. primary outcome measure 5-year recurrence-free survival. Secondary measures comprised overall long-term survival at 5 years...